Q2 2026 delivered strong sales and EBITDA growth, driven by internal cost savings and operational improvements, despite weak demand and volatile input costs. Full-year EBITDA guidance was raised, with all segments showing year-over-year growth, especially in specialty chemicals and semiconductor po…
Q2 2026 delivered strong sales and EBITDA growth, driven by internal cost savings and operational improvements, despite weak demand and volatile input costs. Full-year EBITDA guidance was raised, with all segments showing year-over-year growth, especially in specialty chemicals and semiconductor polysilicon.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
